Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Luciani

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Recenti Progressi in Medicina|January 27, 2015
[Cancer treatment in elderly patients: evidence and clinical research]Lazzaro Repetto, Andrea Luciani
Seminars in Oncology|April 28, 2004
Multiple primary malignanciesAndrea Luciani, Lodovico Balducci
Journal of Geriatric Oncology|September 11, 2023
Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patientsFausto Petrelli, Lorenzo Dottorini, Andrea Luciani
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 7, 2017
An Unusual Case of Myocardial Localization of Non-Small Cell Lung Cancer Metastasis: A Case Report and Review of LiteratureLuca Tagliabue, Giulia Manfrinato, Andrea Luciani
Molecular and Clinical Oncology|September 3, 2021
Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studiesFausto Petrelli, Antonio Ghidini, Andrea Luciani
Drugs & Aging|October 21, 2021
Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World StudiesAndrea Luciani, Antonio Ghidini, Lorenzo Dottorini, et al.
Tumori|November 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?Fausto Petrelli, Gianluca Perego, Ivano Vavassori, et al.
Human Vaccines & Immunotherapeutics|December 3, 2021
Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?Gianluca Perego, Antonio Ghidini, Andrea Luciani, et al.
Anti-Cancer Drugs|March 25, 2024
Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLCAndrea Luciani, Lorenzo Dottorini, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy|August 28, 2009
A review on the treatment of relapsed/metastatic head and neck cancerDaris Ferrari, Carla Codecà, Jessica Fiore, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Recenti Progressi in Medicina|January 27, 2015
[Cancer treatment in elderly patients: evidence and clinical research]Lazzaro Repetto, Andrea Luciani
Seminars in Oncology|April 28, 2004
Multiple primary malignanciesAndrea Luciani, Lodovico Balducci
Journal of Geriatric Oncology|September 11, 2023
Prognostic relevance of sidedness in older patients with colon cancer: A review and pooled analysis of 227,218 patientsFausto Petrelli, Lorenzo Dottorini, Andrea Luciani
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|July 7, 2017
An Unusual Case of Myocardial Localization of Non-Small Cell Lung Cancer Metastasis: A Case Report and Review of LiteratureLuca Tagliabue, Giulia Manfrinato, Andrea Luciani
Molecular and Clinical Oncology|September 3, 2021
Topotecan or other agents as second-line therapy for relapsed small-cell lung cancer: A meta-analysis of randomized studiesFausto Petrelli, Antonio Ghidini, Andrea Luciani
Drugs & Aging|October 21, 2021
Safety and Effectiveness of Immune Checkpoint Inhibitors in Older Patients with Cancer: A Systematic Review of 48 Real-World StudiesAndrea Luciani, Antonio Ghidini, Lorenzo Dottorini, et al.
Tumori|November 22, 2021
Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?Fausto Petrelli, Gianluca Perego, Ivano Vavassori, et al.
Human Vaccines & Immunotherapeutics|December 3, 2021
Antibody-drug conjugates in treating older patients suffering from cancer: what is the real value?Gianluca Perego, Antonio Ghidini, Andrea Luciani, et al.
Anti-Cancer Drugs|March 25, 2024
Network meta-analysis of first-line systemic regimens for older patients with advanced NSCLCAndrea Luciani, Lorenzo Dottorini, Elena Battaiotto, et al.
Expert Opinion on Pharmacotherapy|August 28, 2009
A review on the treatment of relapsed/metastatic head and neck cancerDaris Ferrari, Carla Codecà, Jessica Fiore, et al.
Pageof 9